The novel vaccines targeting interleukin-1 receptor type I

CONCLUSION: The vaccines targeting the IL-1R1 would be a novel and promising treatment for the atherosclerosis and myocardial infarction.PMID:38554439 | DOI:10.1016/j.intimp.2024.111941

Source: International Immunopharmacology - March 30, 2024 Category: Allergy & Immunology Authors: Yanzhao Zhou Jianwu Huang Wuqian Mai Wenlong Kuang Xin Li Dingyang Shi Yulu Yang Jiacheng Wu Zhijie Wu Yuhua Liao Zihua Zhou Zhihua Qiu Source Type: research